{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:09:33Z","timestamp":1792498173810,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41390-023-02550-0","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T19:52:10Z","timestamp":1679860330000},"page":"1075-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Standardized growth charts for children with osteogenesis imperfecta"],"prefix":"10.1038","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2539-227X","authenticated-orcid":false,"given":"Marie-Eve","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis H.","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"2550_CR1","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino, A. & Marini, J. C. Osteogenesis imperfecta. Lancet 387, 1657\u20131671 (2016).","journal-title":"Lancet"},{"key":"2550_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2019.04.021","volume":"126","author":"M-E Robinson","year":"2019","unstructured":"Robinson, M.-E. & Rauch, F. Mendelian bone fragility bisorders. Bone 126, 11\u201317 (2019).","journal-title":"Bone"},{"key":"2550_CR3","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","volume":"27","author":"P Trejo","year":"2016","unstructured":"Trejo, P. & Rauch, F. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos. Int. 27, 3427\u20133437 (2016).","journal-title":"Osteoporos. Int."},{"key":"2550_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41436-018-0045-1","volume":"21","author":"M Jain","year":"2019","unstructured":"Jain, M. et al. Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study. Genet Med. 21, 275\u2013283 (2019).","journal-title":"Genet Med."},{"key":"2550_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/JMDH.S113483","volume":"10","author":"C Marr","year":"2017","unstructured":"Marr, C., Seasman, A. & Bishop, N. Managing the patient with osteogenesis imperfecta: a multidisciplinary approach. J. Multidiscip. Healthc. 10, 145\u2013155 (2017).","journal-title":"J. Multidiscip. Healthc."},{"key":"2550_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.gim.2022.05.008","volume":"24","author":"ME Robinson","year":"2022","unstructured":"Robinson, M. E., Rauch, D., Glorieux, F. H. & Rauch, F. Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in Col1a1\/Col1a2. Genet Med. 24, 1920\u20131926 (2022).","journal-title":"Genet Med."},{"key":"2550_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00431-016-2839-y","volume":"176","author":"K Graff","year":"2017","unstructured":"Graff, K. & Syczewska, M. Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI). Eur. J. Pediatr. 176, 311\u2013316 (2017).","journal-title":"Eur. J. Pediatr."},{"key":"2550_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41436-018-0307-y","volume":"21","author":"LA Barber","year":"2019","unstructured":"Barber, L. A. et al. Longitudinal growth curves for children with classical osteogenesis imperfecta (types III and IV) caused by structural pathogenic variants in type I collagen. Genet Med. 21, 1233\u20131239 (2019).","journal-title":"Genet Med."},{"key":"2550_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/01241398-200411000-00025","volume":"24","author":"J Paley","year":"2004","unstructured":"Paley, J. et al. The multiplier method for prediction of adult height. J. Pediatr. Orthop. 24, 732\u2013737 (2004).","journal-title":"J. Pediatr. Orthop."},{"key":"2550_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.bpo.0000161095.15845.7d","volume":"25","author":"D Paley","year":"2005","unstructured":"Paley, D., Matz, A. L., Kurland, D. B., Lamm, B. M. & Herzenberg, J. E. Multiplier method for prediction of adult height in patients with achondroplasia. J. Pediatr. Orthop. 25, 539\u2013542 (2005).","journal-title":"J. Pediatr. Orthop."},{"key":"2550_CR11","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/ajmg.a.61366","volume":"179","author":"GR Mortier","year":"2019","unstructured":"Mortier, G. R. et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am. J. Med. Genet A 179, 2393\u20132419 (2019).","journal-title":"Am. J. Med. Genet A"},{"key":"2550_CR12","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","volume":"27","author":"G Bardai","year":"2016","unstructured":"Bardai, G., Moffatt, P., Glorieux, F. H. & Rauch, F. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos. Int. 27, 3607\u20133613 (2016).","journal-title":"Osteoporos. Int."},{"key":"2550_CR13","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.apmr.2015.06.006","volume":"96","author":"K Montpetit","year":"2015","unstructured":"Montpetit, K., Palomo, T., Glorieux, F. H., Fassier, F. & Rauch, F. Multidisciplinary treatment of severe osteogenesis imperfecta: functional outcomes at skeletal maturity. Arch. Phys. Med. Rehabil. 96, 1834\u20131839 (2015).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"2550_CR14","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1002\/jbmr.3833","volume":"34","author":"ME Robinson","year":"2019","unstructured":"Robinson, M. E., Trejo, P., Palomo, T., Glorieux, F. H. & Rauch, F. Osteogenesis imperfecta: skeletal outcomes after bisphosphonate discontinuation at final height. J. Bone Miner. Res. 34, 2198\u20132204 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"2550_CR15","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1097\/BPO.0000000000001024","volume":"37","author":"F Fassier","year":"2017","unstructured":"Fassier, F. Fassier-Duval telescopic system: how I do it? J. Pediatr. Orthop. 37, S48\u2013S51 (2017).","journal-title":"J. Pediatr. Orthop."},{"key":"2550_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1542\/peds.109.1.45","volume":"109","author":"CL Ogden","year":"2002","unstructured":"Ogden, C. L. et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics Version. Pediatrics 109, 45\u201360 (2002).","journal-title":"Pediatrics"},{"key":"2550_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2982992","volume":"151","author":"TJ Cole","year":"1988","unstructured":"Cole, T. J. Fitting smoothed centile curves to reference data. J. R. Stat. Soc. Ser. A (Stat. Soc.) 151, 385\u2013418 (1988).","journal-title":"J. R. Stat. Soc. Ser. A (Stat. Soc.)"},{"key":"2550_CR18","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1542\/peds.2014-1711","volume":"135","author":"MG Butler","year":"2015","unstructured":"Butler, M. G. et al. Growth charts for non-growth hormone treated Prader-Willi syndrome. Pediatrics 135, e126\u2013e135 (2015).","journal-title":"Pediatrics"},{"key":"2550_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/sim.4780111005","volume":"11","author":"TJ Cole","year":"1992","unstructured":"Cole, T. J. & Green, P. J. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat. Med. 11, 1305\u20131319 (1992).","journal-title":"Stat. Med."},{"key":"2550_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/pr.2015.230","volume":"79","author":"EL Germain-Lee","year":"2016","unstructured":"Germain-Lee, E. L. et al. Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care. Pediatr. Res. 79, 489\u2013495 (2016).","journal-title":"Pediatr. Res."},{"key":"2550_CR21","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1542\/peds.2015-1652","volume":"136","author":"BS Zemel","year":"2015","unstructured":"Zemel, B. S. et al. Growth charts for children with Down syndrome in the United States. Pediatrics 136, e1204\u2013e1211 (2015).","journal-title":"Pediatrics"},{"key":"2550_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0022-3476(78)81152-4","volume":"93","author":"WA Horton","year":"1978","unstructured":"Horton, W. A., Rotter, J. I., Rimoin, D. L., Scott, C. I. & Hall, J. G. Standard growth curves for achondroplasia. J. Pediatr. 93, 435\u2013438 (1978).","journal-title":"J. Pediatr."},{"key":"2550_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ymgmr.2013.10.001","volume":"1","author":"P Patel","year":"2014","unstructured":"Patel, P. et al. Growth charts for patients with Hunter syndrome. Mol. Genet Metab. Rep. 1, 5\u201318 (2014).","journal-title":"Mol. Genet Metab. Rep."},{"key":"2550_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1065-x","volume":"14","author":"NM Muschol","year":"2019","unstructured":"Muschol, N. M. et al. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III). Orphanet J. Rare Dis. 14, 93 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"2550_CR25","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","volume":"146A","author":"AM Montano","year":"2008","unstructured":"Montano, A. M., Tomatsu, S., Brusius, A., Smith, M. & Orii, T. Growth charts for patients affected with Morquio A disease. Am. J. Med. Genet A 146A, 1286\u20131295 (2008).","journal-title":"Am. J. Med. Genet A"},{"key":"2550_CR26","first-page":"1","volume":"18","author":"A Quartel","year":"2015","unstructured":"Quartel, A. et al. Growth charts for individuals with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). JIMD Rep. 18, 1\u201311 (2015).","journal-title":"JIMD Rep."},{"key":"2550_CR27","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/jbmr.1942","volume":"28","author":"IM Ben Amor","year":"2013","unstructured":"Ben Amor, I. M., Roughley, P., Glorieux, F. H. & Rauch, F. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in Col1a1. J. Bone Min. Res. 28, 2001\u20132007 (2013).","journal-title":"J. Bone Min. Res."},{"key":"2550_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1210\/jc.2018-01083","volume":"104","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. Impact of vertebral fractures and glucocorticoid exposure on height deficits in children during treatment of leukemia. J. Clin. Endocrinol. Metab. 104, 213\u2013222 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2550_CR29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1359\/jbmr.091109","volume":"25","author":"F Rauch","year":"2010","unstructured":"Rauch, F., Lalic, L., Roughley, P. & Glorieux, F. H. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J. Bone Min. Res. 25, 1367\u20131374 (2010).","journal-title":"J. Bone Min. Res."},{"key":"2550_CR30","doi-asserted-by":"publisher","first-page":"115547","DOI":"10.1016\/j.bone.2020.115547","volume":"140","author":"D Rauch","year":"2020","unstructured":"Rauch, D. et al. Assessment of longitudinal bone growth in osteogenesis imperfecta using metacarpophalangeal pattern profiles. Bone 140, 115547 (2020).","journal-title":"Bone"},{"key":"2550_CR31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin, L., Rauch, F., Plotkin, H. & Glorieux, F. H. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111, 1030\u20131036 (2003).","journal-title":"Pediatrics"},{"key":"2550_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1302\/0301-620X.72B3.2187879","volume":"72","author":"C Sanguinetti","year":"1990","unstructured":"Sanguinetti, C., Greco, F., De Palma, L., Specchia, N. & Falciglia, F. Morphological changes in growth-plate cartilage in osteogenesis imperfecta. J. Bone Joint Surg. Br. 72, 475\u2013479 (1990).","journal-title":"J. Bone Joint Surg. Br."},{"key":"2550_CR33","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nm.3544","volume":"20","author":"I Grafe","year":"2014","unstructured":"Grafe, I. et al. Excessive transforming growth factor-beta signaling is a common mechanism in osteogenesis imperfecta. Nat. Med. 20, 670\u2013675 (2014).","journal-title":"Nat. Med."},{"key":"2550_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jbmr.3617","volume":"34","author":"JT Tauer","year":"2019","unstructured":"Tauer, J. T., Abdullah, S. & Rauch, F. Effect of anti-TGF-beta treatment in a mouse model of severe osteogenesis imperfecta. J. Bone Min. Res. 34, 207\u2013214 (2019).","journal-title":"J. Bone Min. Res."},{"key":"2550_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/bdrc.21058","volume":"102","author":"W Wang","year":"2014","unstructured":"Wang, W., Rigueur, D. & Lyons, K. M. TGF\u03b2 signaling in cartilage development and maintenance. Birth Defects Res. C. Embryo Today 102, 37\u201351 (2014).","journal-title":"Birth Defects Res. C. Embryo Today"},{"key":"2550_CR36","doi-asserted-by":"publisher","first-page":"115990","DOI":"10.1016\/j.bone.2021.115990","volume":"149","author":"LE Nicol","year":"2021","unstructured":"Nicol, L. E. et al. Alterations of a serum marker of collagen X in growing children with osteogenesis imperfecta. Bone 149, 115990 (2021).","journal-title":"Bone"},{"key":"2550_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpeds.2015.10.058","volume":"169","author":"T Palomo","year":"2016","unstructured":"Palomo, T., Glorieux, F. H., Schoenau, E. & Rauch, F. Body composition in children and adolescents with osteogenesis imperfecta. J. Pediatr. 169, 232\u2013237 (2016).","journal-title":"J. Pediatr."},{"key":"2550_CR38","first-page":"e10174","volume":"3","author":"JT Tauer","year":"2019","unstructured":"Tauer, J. T., Robinson, M. E. & Rauch, F. Osteogenesis imperfecta: new perspectives from clinical and translational research. JBMR 3, e10174 (2019).","journal-title":"JBMR"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02550-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T16:47:37Z","timestamp":1702140457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02550-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02550-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.-E.R. declares study grants to institution from Ascendis Biopharma and Ipsen Biopharmaceuticals and consultancy fees to institution from Ipsen Biopharmaceuticals and Ultragenyx. D.R. has no conflicts of interest to declare. F.H.G. declares consulting fees and research grants from Novartis, Amgen, Mereo Biopharma and Ultragenyx. F.R. reports study grants to institution from PreciThera Inc, Ultragenyx Inc and Catabasis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}